Stem Cell Treatment for Heart Disease
BPIH is one of the earliest institutions that clinically carry out stem cell therapy for heart diseases. Over the past 10 years, we’ve treated patients from all over the world, and most of them gained different levels of improvements after the treatment.
1. 1st top intelligent robot of vascular machine in Asia: IGS 730
2. Word-class stem cell laboratory
3. Internationalized medical team
About Stem Cell Treatment
1- Advantages of stem cell treatment for heart diseases:
Low risks: Compared with heart transplantation and other conventional therapies, stem cell treatment causes no pain and much safer with almost no risk.
High effects: treatment effects of stem cell therapy are more obvious compared with other therapies.
Repeatable: as a more effective and low risk therapy, patient can repeat the treatment to achieve continuous improvement.
Wide application: stem cell therapy is applicable for patients age from 1~80, which provide more treatment options for both young children and senior people.
- Heart Failure;
- Ischemic Heart Disease;
- Congenital Heart Disease;
- Coronary Heart Disease;
- Atherosclerotic Cardiovascular Disease.
3- The mechanism of stem cell treatment for heart disease
1） Cardiac Differentiation Mechanism: 1) stem cell is under catalysis of PI3 – K, etc. through proliferation, migration, differentiation, survival and participates in the myocardial cell differentiation. After modification such as Lim, inject stem cell into myocardial infarction area through coronary artery, clearly show anti-apoptosis ability, to repair the myocardium. In recent years many experiments proved that after patients received stem cell transplantation within 12 weeks, the ventricular wall obviously thickening in infarction area, wall motion score index significantly decreased.
2) Paracrine action: stem cell transplantation increasing the release of cytokines (such as VEGF, etc.), and acting on surrounding cells through the gap, play physiological function by regeneration of blood vessels, anti-apoptosis, promoting mitosis, homing and immune regulation, etc. After scientists inject stem cells into myocardial infarction model for only two weeks, left ventricular cardiac function improved, capillary density increased significantly, transplant area of VEGF expression significantly raised.
Through the above mechanism, under the abduction of local microenvironment, stem cell transplantation can promote release of related cytokines, and differentiate into myocardial cells, endothelial cells, smooth muscle cells, etc. These cells can effectively restore myocardial contractility and viability, reduce ventricular expansion and myocardial infarction area, save the dying myocardium, and improve the perfusion and myocardial function.
This will greatly improve patients’ life quality, which is the most suitable choice for patients with heart disease.
Dr. Yanjun JIA, Chief Cardiologist
Dr. Jia has been devoted herself to scientific research and clinical treatment for heart disease for nearly 20 years. After getting her Doctor Degree in Japan, Dr. Jia came back to China and worked in China’s top Cardiovascular Hospital: Beijing Fuwai Hospital. Beijing Fuwai Hospital is one of the largest Cardiovascular Hospitals in the world, where Dr Jia obtained her Post-doctor Degree and accumulated valuable experience, including stem cell therapy for heart diseases. As one of the outstanding cardiologists, Dr. Jia has published several academic papers on SCI journals.
Currently, Dr. Jia is working in Beijing Puhua International Hospital, as the Chief Cardiologist for both clinical treatment and scientific research.
Areas of Specialization: stem cell therapy for coronary heart disease, heart failure, ischemic heart disease, congenital heart disease, coronary heart disease, atherosclerosis cardiovascular disease.
CARDIOLOGY CASE STUDIES
Name: Haji Abdul Ghani
Diagnosis: Coronary Heart Disease; Remote Infarct; Chronic Heart Failure; Type II Diabetes Mellitus; Chronic Kidney Failure
D.O.B: 01 January 1947
Name: Mr. Huan
Diagnosis: Dilated Cardiomyopathy, Chronic Congestive Heart Failure. Other diagnoses include: Cardiac Arrhythmia, Gout, Hypothyroidism, Postoperative and Post-Chemotherapy for Lymphoma, Psoriasis, Kidney Damage, Gastro-enteritis
D.O.B: 02 December 1964
Name: John Clarke
Diagnosis: Dilated Cardiomyopathy (DCM); Atherosclerosis; Cardiac Failure-Functional Class Ⅲ; Pacemaker Implantation After Surgery; Hx of Transient Ischemic Attack; COPD; Severe Obesity; Type 2 Diabetes; Mixed Sleep Apnea Syndrome; Peripheral Vascular Disease; Intercostal Neuralgia
D.O.B: 12 February 1962
Name: Leon King
Diagnosis: Dilated Cardiomyopathy
D.O.B: 01 January 1972
Country: United States of America